Cargando…
Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
BACKGROUND: Chloroquine (CQ) and its derivative hydroxychloroquine (HCQ) have recently emerged as potential antiviral and immunomodulatory options for the treatment of 2019 coronavirus disease (COVID-19). To examine the safety profiles of these medications, we systematically evaluated the adverse ev...
Autores principales: | Ren, Lu, Xu, Wilson, Overton, James L., Yu, Shandong, Chiamvimonvat, Nipavan, Thai, Phung N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591721/ https://www.ncbi.nlm.nih.gov/pubmed/33154723 http://dx.doi.org/10.3389/fphar.2020.562777 |
Ejemplares similares
-
Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis
por: Ren, Lu, et al.
Publicado: (2021) -
The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
por: Manivannan, Elangovan, et al.
Publicado: (2021) -
Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine
por: Ngai, Jamie, et al.
Publicado: (2022) -
Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
por: Chen, Yan, et al.
Publicado: (2020) -
Protocol to record and quantify the intracellular pH in contracting cardiomyocytes
por: Lyu, Yankun, et al.
Publicado: (2022)